Neuphoria Therapeutics Inc. Common Stock (NASDAQ: NEUP) last traded at $3.32, down 1.19% on the session. The quote above updates while this page is open; the figures below are drawn from Neuphoria Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Neuphoria Therapeutics Inc. Common Stock trades on NASDAQ under the ticker NEUP. Its market capitalisation is $17.97 million.
Valuation measures for Neuphoria Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $17.97M |
|---|---|
| Enterprise value | $2.21M |
| Price / sales | 15.30 |
| Price / book | 0.73 |
| Beta | 1.08 |
Trailing-twelve-month figures tagged in Neuphoria Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.17M |
|---|---|
| Net income (TTM) | -$13.45M |
| EPS (TTM) | -$3.06 |
| Operating margin | -1401.09% |
| Return on equity | -54.68% |
| Cash | $19.87M |
Range and volume for NEUP over the past 52 weeks.
| 52-week high | $17.90 |
|---|---|
| 52-week low | $3.19 |
| Volume | 9.9K |
| Average volume | 159.2K |
| Previous close | $3.36 |
Invest a chosen dollar amount in Neuphoria Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NEUP.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.